Jupiter Neurosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Jupiter Neurosciences generated cash of -$1,735,046, which is less than the previous year. Cash used in financing activities reached the amount of $1,857,650 last year. Net change in cash is therefore $122,604.
Cash Flow
| 2019 | -142.95K | 0 | 107.79K |
|---|---|---|---|
| 2020 | -254.78K | 0 | 461.50K |
| 2021 | -1.73M | 0 | 1.85M |
JUNSW Cash Flow Statement (2019 – 2021)
| 2021 | 2020 | 2019 | |
|---|---|---|---|
Cash at beginning of period | 207.99K | 1.27K | 36.43K |
Operating activities | |||
Net income | -4.20M | -1.65M | -3.04M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||
Depreciation and amortization | 0 | 0 | 0 |
Stock-based compensation expense | 1.30M | 501.03K | 944.57K |
| Deferred income tax benefit | 1.30M | 501.03K | 944.57K |
| Changes in operating assets and liabilities: | |||
Accounts receivable, net | 126.23K | -126.23K | 0 |
Inventories | -32.80K | 44.96K | 0 |
Accounts payable | -155.25K | 185.95K | 162.73K |
Cash generated by operating activities | -1.73M | -254.78K | -142.95K |
Investing activities | |||
Purchases Of Investments | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 |
Acquisitions Net | 0 | 0 | 0 |
Cash generated by investing activities | 0 | 0 | 0 |
Financing activities | |||
Common Stock Issued | 0 | 700.00K | 0 |
Payments for dividends | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 |
Repayments of term debt | 0 | -253.49K | 0 |
Cash used in financing activities | 1.85M | 461.50K | 107.79K |
Net Change In Cash | 122.60K | 206.72K | -35.16K |
Cash at end of period | 330.60K | 207.99K | 1.27K |